Relationship of the effects of nigericin on the aggregation and cytoplasmic pH of bovine platelets in the presence of different cations.
The effect of nigericin on aggregation of bovine platelets was investigated in media containing the chloride salts of various alkali metal cations of quaternary ammonium cations. In medium with K+, which has the highest permeability with the ionophore among the cations tested, nigericin slightly enhanced both ADP- and thrombin-induced aggregation. In medium with Na+, nigericin scarcely affected ADP-induced aggregation, and slightly inhibited thrombin-induced aggregation. In media with Cs+, choline and tetramethylammonium, it inhibited the aggregations induced by both ADP and thrombin. Measurement of the cytoplasmic pH with the fluorescent probe 2',7'-bis(carboxyethyl)5,6-carboxyfluorescein showed that nigericin increased the intracellular pH in K+ medium and caused its stable decrease (of about 0.6) in Cs+, choline and tetramethylammonium media, but caused only a small transient decrease in medium with Na+. These results suggest that the effects of nigericin on platelet aggregation are mainly due to its effects on the cytoplasmic pH. This conclusion is supported by the findings that the effects on platelet aggregation of other types of ionophore tested were also proportional to their effects on the cytoplasmic pH.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002412:Cations; D002417:Cattle; D002586:Cesium / Q000494:pharmacology; D002794:Choline / Q000494:pharmacology; D003593:Cytoplasm; D006096:Gramicidin / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D009550:Nigericin / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011188:Potassium / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D014634:Valinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002412:Cations; D000644:Quaternary Ammonium Compounds; D006096:Gramicidin; D002586:Cesium; D014634:Valinomycin; D000244:Adenosine Diphosphate; D012964:Sodium; D013917:Thrombin; C027917:tetramethylammonium; D002794:Choline; D009550:Nigericin; D011188:Potassium